A Phase II Clinical Trial of SHR-1826 for Non-Small Cell Lung Cancer

Clinical trial NCT07489716 · RECRUITING

Trial details

NCT number: NCT07489716
Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2026-04-29
Primary completion: 2028-08-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.